US Patent Issued to The Trustees of the University of Pennsylvania on May 12 for "Monoclonal antibodies against pathological tau, and methods of detection thereof" (Pennsylvania Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,095, issued on May 12, was assigned to The Trustees of the University of Pennsylvania (Philadelphia). "Monoclonal antibodies against patholo... Read More

US Patent Issued to GTInvent on May 12 for "Anti-tau antibodies and methods of use thereof" (British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,096, issued on May 12, was assigned to GTInvent Ltd. (Aberdeen, Great Britain). "Anti-tau antibodies and methods of use thereof" was invente... Read More

US Patent Issued to MEDICOVESTOR on May 12 for "Nucleic acids, vectors, and cells that encode anti-Sp17 antibodies and other Sp17 binding proteins" (Delaware Inventor)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,097, issued on May 12, was assigned to MEDICOVESTOR INC. (Wilmington, Del.). "Nucleic acids, vectors, and cells that encode anti-Sp17 antibo... Read More

US Patent Issued to Hoffmann-La Roche, Genentech on May 12 for "Treatment of age-related macular degeneration and diabetic macular edema by administration of a bispecific antibody to VEGF and ANG-2" (Swiss, American Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,098, issued on May 12, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.) and Genentech Inc. (South San Francisco, Calif.). "Treatm... Read More

US Patent Issued to ABCLON on May 12 for "Polypeptide improved in protein purity and affinity for antigen, conjugate thereof with antibody or antigen-binding fragment, and preparation method therefor" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,099, issued on May 12, was assigned to ABCLON INC. (Seoul, South Korea). "Polypeptide improved in protein purity and affinity for antigen, c... Read More

US Patent Issued to SOTIO BIOTECH on May 12 for "Humanized CLDN18.2 antibodies" (Swiss, Czech, German Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,100, issued on May 12, was assigned to SOTIO BIOTECH A.S. (Prague). "Humanized CLDN18.2 antibodies" was invented by Lukas Bammert (Basel, Sw... Read More

US Patent Issued to Celex Oncology Innovations on May 12 for "Monoclonal antibodies against neonatal Na v 1.5" (British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,101, issued on May 12, was assigned to Celex Oncology Innovations Ltd. (London). "Monoclonal antibodies against neonatal Na v 1.5" was inven... Read More

US Patent Issued to Rutgers, The State University of New Jersey on May 12 for "CD147 chimeric antigen receptors and methods of use" (New Jersey Inventor)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,102, issued on May 12, was assigned to Rutgers, The State University of New Jersey (New Brunswick, N.J.). "CD147 chimeric antigen receptors ... Read More

US Patent Issued to Yuhan on May 12 for "Engineered antibodies that bind LAG3" (California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,103, issued on May 12, was assigned to Yuhan Corp. (Seoul, South Korea). "Engineered antibodies that bind LAG3" was invented by Damien Bress... Read More

US Patent Issued to LENTIGEN TECHNOLOGY, THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services on May 12 for "Compositions and methods for treating cancer with anti-CD19 immunotherapy" (Maryland, Washington Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,104, issued on May 12, was assigned to LENTIGEN TECHNOLOGY INC. (Gaithersburg, Md.) and THE UNITED STATES OF AMERICA, as represented by the S... Read More

• ««
• «
• 12352
• 12353
• 12354
• 12355
• 12356
• 12357
• 12358
• 12359
• 12360
• 12361
• »
• »»